You have no items in your shopping cart.
Vidofludimus
SKU: orb1305278
Description
Research Area
Cell Biology, Immunology & Inflammation, Metabolism Research, Molecular Biology
Images & Validation
−
Key Properties
−| CAS Number | 717824-30-1 |
|---|---|
| MW | 355.36 |
| Purity | 99.58% (May vary between batches) |
| Formula | C20H18FNO4 |
| SMILES | COc1cccc(c1)-c1ccc(NC(=O)C2=C(CCC2)C(O)=O)c(F)c1 |
| Target | DNA/RNA Synthesis,FXR,Dehydrogenase,Interleukin |
| Solubility | H2O:< 1 mg/mL (insoluble or slightly soluble);10% DMSO+90% Corn Oil:3.3 mg/mL (9.29 mM);DMSO:100 mg/mL (281.4 mM);Ethanol:1 mg/mL (2.81 mM) |
Bioactivity
−| Target IC50 | |
|---|---|
| In Vivo | |
| In Vitro |
Storage & Handling
−| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
|---|---|
| Expiration Date | 12 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−RNA Synthesis, RNASynthesis, SC 12267, SC12267, SC-12267, Vidofludimus, 4sc-101, DHODH, Dihydroorotate Dehydrogenase, DNASynthesis, DNA/RNA Synthesis, DNA Synthesis, dihydroorotate dehydrogenase (DHODH), Inhibitor, Interleukin Related, Interleukin, farnesoid X receptor (FXR), fatty liver, Human DHODH, FXR, immunomodulatory, inflammatory bowel disease (IBD), NR1H4, inhibit, non-alcoholic fatty liver disease (NAFLD), oral
Similar Products
−Vidofludimus [orb1223067]
>98% (HPLC)
717824-30-1
355.36
C20H18FNO4
1 g, 500 mg, 200 mg, 25 mg, 10 mg, 50 mg, 100 mg, 5 mg, 2 mg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
Compound Identifiers
PubChem CID
Key Properties
− No computed properties available.
Documents Download
Datasheet
Product Information
Request a Document
Protocol Information
Vidofludimus (orb1305278)
Based on 0 reviews
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review